Why the study?
Wearables offer continuous biomarker monitoring for early cardiovascular disease detection, but standard ML models require labor-intensive labeling; data-efficient ML methods are needed.
Can a data-efficient machine learning model detect atrial fibrillation and heart failure from continuous wearable data?
Observational (n=200)
No
Can a data-efficient machine learning model detect atrial fibrillation and heart failure from continuous wearable data?
The ME-TIME study aims to develop data-efficient machine learning models to detect atrial fibrillation and heart failure using continuous data from consumer smartwatches.
Hypothesis-generating for wearable heart disease detection; leaves open clinical utility in AF/HF models pending validation.
Background: Smartwatches enable continuous and noninvasive time series monitoring of cardiovascular biomarkers like heart rate (from photoplethysmograms), step counter, skin temperature, et cetera; as such, they have promise in assisting in early detection and prevention of cardiovascular disease. Although these biomarkers may not be directly useful to physicians, a machine learning (ML) model could find clinically relevant patterns. Unfortunately, ML models typically need supervised (ie, annotated) data, and labeling of large amounts of continuous data is very labor intensive. Therefore, ML methods that are data efficient, ie, needing a low number of labels, are required to detect potential clinical value in patterns found in wearable data. Objective: The primary study objective of the ME-TIME (Machine Learning Enabled Time Series Analysis in Medicine) study is to design an ML model that can detect atrial fibrillation (AF) and heart failure (HF) from wearable data in a data-efficient manner. To achieve this, self-supervised and weakly supervised learning techniques are used. Methods: Two hundred subjects (100 reference, 50 AF, and 50 HF) are being invited to participate in wearing a Fitbit fitness tracker for 3 months. Interested volunteers are sent a questionnaire to determine their health, in particular cardiovascular health. Volunteers without any (history of) serious illness are assigned to the reference group. Participants with AF and HF are recruited in the Haga teaching hospital in The Hague, The Netherlands. Results: Enrollment commenced on May 1, 2022, and as of the time of this report, 62 subjects have been included in the study. Preliminary analysis of the data reveals significant inter-subject variability. Notably, we identified heart rate recovery curves and time-delayed correlations between heart rate and step count as potential strong indicators for heart disease. Conclusion: Using self-supervised and multiple-instance learning techniques, we hypothesize that patterns specific to AF and HF can be found in continuous data obtained from smartwatches.
No takes yet. Share an insight, caveat, or question.
Jahfari et al. (2023) conducted an observational in Atrial fibrillation and heart failure (n=200). Continuous wearable data monitoring (Fitbit) vs. Healthy reference group was evaluated on Detection of atrial fibrillation and heart failure using a machine learning model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: